Targeted Cancer Screening in Average-Risk Individuals

American Journal of Preventive Medicine

Volumn 49, Issue 5, 2015, Pages 765-771

  Marcus, Pamela M ^a   Freedman, Andrew N ^a   Khoury, Muin J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; EXPERIENCE; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GROUPS BY AGE; HEREDITY; HUMAN; INTERMEDIATE RISK POPULATION; LUNG CANCER; MEDICAL SOCIETY; POPULATION RISK; PRACTICE GUIDELINE; PROSTATE CANCER; RACE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SMOKING; TARGETED CANCER SCREENING; UNITED STATES; UTERINE CERVIX CANCER; EARLY CANCER DIAGNOSIS; MASS SCREENING; NEOPLASMS; PROCEDURES; RISK FACTOR;

EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84945475796     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2015.04.030     Document Type: Article

References (38)

1. A.S. Morrison Screening in Chronic Disease 2nd ed. 1992 Oxford University Press New York
2. U.S. Preventive Services Task Force. Screening for breast cancer. www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm. Published November 2009. Accessed July 10, 2014.
3. U.S. Preventive Services Task Force. Screening for cervical cancer. www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Published March 2012. Accessed July 17, 2014.
4. U.S. Preventive Services Task Force. Screening for colorectal cancer. www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm. Published October 2008. Accessed July 17, 2014.
5. U.S. Preventive Services Task Force. Screening for lung cancer. www.uspreventiveservicestaskforce.org/uspstf/uspslung.htm. Published December 2013. Accessed July 17, 2014.
6. Raffle A, Gray M. Screening: Evidence and Practice. Oxford: Oxford University Press; 2007. http://dx.doi.org/10.1093/acprof:oso/9780199214495.001.0001.
7. M.J. Khoury, ACJW Janssens, and D.F. Ransohoff How can polygenic inheritance be used in population screening for common diseases? Genet Med 15 6 2013 437 443 10.1038/gim.2012.182
8. M.G. Dunlop, A. Tenesa, S.M. Farrington, and et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals Gut 62 6 2013 871 881 10.1136/gutjnl-2011-300537
9. S. Wacholder, P. Hartge, R. Prentice, and et al. Performance of common genetic variants in breast-cancer risk models N Engl J Med 362 11 2012 986 993 10.1056/NEJMoa0907727
10. R.A. Eeles, A.A. Olama, S. Benlloch, and et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array Nat Genet 45 4 2013 385 391 10.1038/ng.2560
11. K. Michailidou, P. Hall, A. Gonzalez-Neira, and et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk Nat Genet 45 4 2013 353 361 10.1038/ng.2563
12. American Urologic Association. Early detection of prostate cancer. www.auanet.org/education/guidelines/prostate-cancer-detection.cfm. Published April 2013. Accessed July 10, 2014
13. National Cancer Institute. SEER Cancer Statistics Review, 1975-2011. www.seer.cancer.gov/csr/1975-2011/. Published December 17, 2014. Accessed July 29, 2014.
14. V. Brower Breast density legislation fueling controversy J Natl Cancer Inst 105 8 2013 510 511 10.1093/jnci/djt086
15. H. Brenner, J. Chang-Claude, C.M. Seller, and M. Hoffmeister Long-term risk of colorectal cancer after negative colonoscopy J Clin Oncol 29 28 2011 3761 3767 10.1200/JCO.2011.35.9307
16. A.B. Knudsen, C. Hur, G.S. Gazelle, D. Schrag, E.G. McFarland, and K.M. Kuntz Rescreening of persons with a negative colonoscopy result: results from a microsimulation model Ann Intern Med 157 9 2012 611 620 10.7326/0003-4819-157-9-201211060-00005
17. V.A. Moyer U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157 2 2012 120 134
18. R.A. Smith, D. Brooks, V. Cokkinides, D. Saslow, and O.W. Brawley Cancer screening in the US, 2014 CA Cancer J Clin 64 1 2014 30 51 10.3322/caac.21212
19. American College of Obstetricians-Gynecologists Practice bulletin no. 122: breast cancer screening Obstet Gynecol 118 2, pt 1 2011 372 382
20. American College of Obstetricians-Gynecologists Practice bulletin no. 131: cervical cancer screening Obstet Gynecol 120 5 2012 1222 1238
21. D.K. Rex, D.A. Johnson, J.C. Anderson, P.S. Schoenfeld, C.A. Burke, and J.M. Inadomi Colorectal cancer screening Am J Gastroenterol 104 3 2009 739 750 10.1038/ajg.2009.104
22. F.C. Detterbeck, S. Zelman Lewis, R. Diekemper, D. Addrizzo-Harris, and W.M. Alberts Diagnosis and management of lung cancer, 3rd edition: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 5 suppl 2013 7S 37S
23. National Comprehensive Cancer Network. Lung cancer screening. www.rrmginc.com/docs/NCCN-GuidelinesLungCancerScreening.pdf. Published October 26, 2011. Accessed July 10, 2014.
24. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group The EGAPP initiative: lessons learned Genet Med 16 3 2014 217 224 10.1038/gim.2013.110
25. P.C. Prorok, B.S. Kramer, and J.K. Gohagan Screening theory and study design: the basics B.S. Kramer, J.K. Gohagan, P.C. Prorok, Cancer Screening: Theory and Practice 1999 Marcel Dekker New York 29 53
26. B. Freidlin, and E.L. Korn A model too far J Natl Cancer Inst 106 2 2014 djt368 10.1093/jnci/djt368
27. Kuntz K, Sainfort F, Butler M, et al. Decision and Simulation Modeling in Systematic Reviews. Methods Research Report. Rockville MD: Agency for Healthcare Research and Quality, 2013. AHRQ Publication No. 11(13)-EHC037-EF. www.effectivehealthcare.ahrq.gov/ehc/products/511/1410/Methods-Decision-Simulation-Modeling-130221.pdf.
28. N.B. Gunsoy, M. Garcia-Closas, and S.M. Moss Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom Br J Cancer 110 10 2014 2412 2419 10.1038/bjc.2014.206
29. N. Pashayan, S.W. Duffy, S. Chowdhury, and et al. Polygenic susceptibility to prostate and breast cancer: implications for personalized screening Br J Cancer 104 10 2011 1656 1663 10.1038/bjc.2011.118
30. A. Brandt, J.L. Bermejo, J. Sundquist, and K. Hemminki Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affect family members Eur Urol 58 2 2010 275 280 10.1016/j.eururo.2010.02.002
31. L.C. Walter, and M.A. Schonberg Screening mammography in older women: a review JAMA 311 13 2014 1336 1347 10.1001/jama.2014.2834
32. V.A. Moyer Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 160 5 2014 330 338 10.7326/M13-2771
33. H.J. De Koning, R. Meza, S.K. Plevritis, and et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force Ann Intern Med 160 5 2014 311 320 10.7326/M13-2316
34. S. Agrawal, A. Bhupinderjig, M.S. Bhutani, and et al. Colorectal cancer in African Americans Am J Gastroenterol 100 6 2005 515 523 10.1111/j.1572-0241.2005.41829.x
35. National Cancer Institute. SEER Cancer Statistics Review, 1975-2011. http://seer.cancer.gov/csr/1975-2012/. Published April 2015. Accessed June 12, 2015.
36. S.L. Kulasingam, L.J. Havrilesky, R. Ghebre, and E.R. Myers Screening for cervical cancer: a modeling study for the US Preventive Services Task Force J Low Genit Tract Dis 17 2 2013 193 202 10.1097/LGT.0b013e3182616241
37. National Cancer Institute. Breast Cancer Surveillance Consortium. http://breastscreening.cancer.gov/.
38. National Cancer Institute. PROSPR: Population-based Research Optimizing Screening through Personalized Regimens. http://appliedresearch.cancer.gov/prospr/.